Weber, Britta <br/><br/>
EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Feb 2014 
 - 224-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2013.11.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--diagnosis<br/>Denmark<br/>Disease-Free Survival<br/>ErbB Receptors--genetics<br/>Erlotinib Hydrochloride<br/>Female<br/>Humans<br/>Lung Neoplasms--diagnosis<br/>Male<br/>Middle Aged<br/>Mutation--genetics<br/>Predictive Value of Tests<br/>Prognosis<br/>Prospective Studies<br/>Quinazolines--administration & dosage<br/>Survival Analysis<br/>Treatment Outcome